(Q35565909)

8 August 2017

title

Early therapeutic experience with the endothelin antagonist BQ-123 in pulmonary hypertension after congenital heart surgery (English)

1 reference

8 August 2017

0 references

0 references

pulmonary hypertension

1 reference

B Prendergast

1

1 reference

8 August 2017

D E Newby

2

1 reference

8 August 2017

L E Wilson

3

1 reference

8 August 2017

D J Webb

4

1 reference

8 August 2017

P S Mankad

5

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

8 August 2017

1 reference

8 August 2017

volume

82

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

505-508

1 reference

EndothelinA receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension

8 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

The endothelin system and its potential as a therapeutic target in cardiovascular disease.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Increased pulmonary blood flow alters the molecular regulation of vascular reactivity in the lamb

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Blockade of endothelin-converting enzyme reduces pulmonary hypertension after cardiopulmonary bypass and circulatory arrest.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Endothelin-1 in pulmonary hypertension associated with high-altitude exposure

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1760282

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

24 October 2018

1 reference

12 December 2020

Short-term haemodynamic effects of BQ-123, a selective endothelin ET(A)-receptor antagonist, in chronic heart failure

1 reference

12 December 2020

Increased plasma levels of endothelin-1 after cardiopulmonary bypass in patients with pulmonary hypertension and congenital heart disease

1 reference

12 December 2020

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

12 December 2020

Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in humans

1 reference

12 December 2020

Human pulmonary circulation is an important site for both clearance and production of endothelin-1

1 reference

12 December 2020

Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn

1 reference

12 December 2020

Post-cardiopulmonary bypass pulmonary hypertension in lambs with increased pulmonary blood flow. A role for endothelin 1

1 reference

12 December 2020

Endothelin-1 in the lungs of patients with pulmonary hypertension

1 reference

12 December 2020

The orally active ET(A) receptor antagonist (+)-(S)-2-(4,6-dimethoxy-pyrimidin-2-yloxy)-3-methoxy-3,3-diphe nyl-propionic acid (LU 135252) prevents the development of pulmonary hypertension and endothelial metabolic dysfunction in monocrotaline-trea

1 reference

12 December 2020

Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity

1 reference

12 December 2020

Identifiers

0 references

1 reference

8 August 2017

1 reference